NYSE · Healthcare · Medical Instruments & Supplies · USA
Teleflex Incorporated is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.
Teleflex designs and manufactures single-use medical devices for hospitals and healthcare providers globally, serving vascular access, emergency medicine, interventional and surgical applications. The company markets its products through direct sales forces and distributors worldwide, with production facilities located in Central Europe, Southeast Asia, North America and Mexico.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Teleflex Incorporated stock.
Overvalued: intrinsic value $11.24 per share, market price $129.68, margin of safety -1053.3% (as of 2026-10-19).
Discounting its cash flows at 8.4% values the shares at $11.24; the price of $129.68 is 1053% above that value, and 78% of that value comes from beyond year five.
Leak Score: 33/100 on 10 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
22 more in this industry show a wider margin of safety.
TFX is overvalued (as of the 2026-10-19 close). Discounting its cash flows at 8.4% values the shares at $11.24; the price of $129.68 is 1053% above that value, and 78% of that value comes from beyond year five.
$11.24 per share (as of the 2026-10-19 close), against a market price of $129.68. That is a margin of safety of -1053.3%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
33 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.